Scorpio Tankers Inc. Announces Financial Results for the Fourth Quarter of 2024 and the Declaration of a Dividend
MONACO, Feb. 12, 2025 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE: STNG) (“Scorpio Tankers” or the “Company”) today reported its […]
Kadant Reports Fourth Quarter and Fiscal Year 2024 Results
WESTFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) reported its financial results for the fourth quarter […]
Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Changes
NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) — Brookfield Public Securities Group LLC (“PSG”) today announced upcoming changes to the […]
Hubbell Incorporated Declares New Share Repurchase Program
Shelton, CT, Feb. 12, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today approved a new […]
GXO Reports Fourth Quarter and Full Year 2024 Results
Delivered record revenue for both Q4 and full year 2024 Organic revenue growth accelerated sequentially each quarter in 2024 Closed […]
Global Ship Lease Declares Quarterly Dividend per Common Share for Fourth Quarter of 2024
ATHENS, Greece, Feb. 12, 2025 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced […]
QXO Proposes Full Slate of Independent Directors for Election at Beacon Roofing Supply’s 2025 Annual Meeting
GREENWICH, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) — QXO, Inc. (NYSE: QXO) announced today that it has informed Beacon Roofing […]
ARMOUR Residential REIT, Inc. Announces Q4 Results and December 31, 2024 Financial Position
VERO BEACH, Florida, Feb. 12, 2025 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR PRC) (“ARMOUR” or […]
Victoria’s Secret & Co. Invites You to Listen to the Fourth Quarter 2024 Earnings Call Webcast
REYNOLDSBURG, Ohio, Feb. 12, 2025 (GLOBE NEWSWIRE) — In conjunction with the Victoria’s Secret & Co. (NYSE: VSCO) fourth quarter […]
Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors
HUNTSVILLE, AL, Feb. 12, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing […]
